ACE and hyperhomocysteinemia: In the presented patient, the presence of the ACE I/D DD genotype likely exacerbated the effects of the PAI-1 4G/5G polymorphism and hyperhomocysteinemia by promoting a proinflammatory, prothrombotic, and antifibrinolytic vascular environment.